Related Experiment Video
Updated: Apr 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Complementary and alternative medicine use at a single pediatric inflammatory bowel disease center
Clare Ceballos1, Ruijun Bao, David Dunkin
1Clare Ceballos, PNP, is Pediatric Nurse Practitioner, the Mount Sinai Hospital, Division of Pediatric Gastroenterology, New York City, New York. Ruijun Bao, MD, is Data Analyst, Division of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York. David Dunkin, MD, is Assistant Professor, Division of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York. Ying Song, MD, is Instructor, Division of Pediatric Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York City, New York. Xiu-Min Li, MD, is Professor, Division of Pediatric Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York City, New York. Keith Benkov, MD, is Associate Professor, Division of Pediatric Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York.
Abstract:
The aim of this study was to determine the use of complementary and alternative medicine (CAM) in an inflammatory bowel disease population at a single pediatric center. The secondary aims were to determine predictors of CAM use and assess parental attitude to CAM use. A survey was developed that was distributed electronically and given out in the clinic. Two hundred thirty-five surveys were analyzed. Thirty-six percent of respondents reported that their children had used CAM, while 19.6% were current users. Sixty-three percent of respondents were "extremely" or "very supportive" of CAM and 57.6% would have been "extremely" or "very supportive" at the time of their children's diagnosis. The most commonly used CAM modalities were fish oil (48.8%), probiotics (22.5%), acupuncture/pressure (17.5%), aloe (16.3%), yoga/meditation (16.3%), chiropractic (12%), and herbal medicine (13.8%). Multivariate analysis revealed 2 independent factors predictive of subjects using CAM: use of biologics (odds ratio of 2.8; p = .008) and subjects' parent using CAM (odds ratio of 10.9; p ≤ .001). More than one third of children in this study and their parents have used CAM. Families are supportive of CAM both at the time of diagnosis and as an ongoing component of their child's treatment even if they were not past or current users of CAM. Predictors of CAM use were treatment with a biologic and having a parent who used CAM.
More Related Videos
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF